ETView Announces Appointment of Javier Campos, MD to its Scientific Advisory Board

ETView Medical Ltd. (TASE: ETVW), a commercial stage medical device company traded on the Tel Aviv stock exchange, announced today the appointment of Javier Campos, MD to its Scientific Advisory Board. Dr. Campos currently holds the positions of Clinical Professor, Executive Medical Director of Operating Rooms; Vice Chair, Clinical Affairs, and Director of Cardiothoracic Anesthesia for the University of Iowa. Dr. Campos has published over 42 peer-reviewed scientific articles in the field of cardiothoracic anesthesia, with over 20 articles devoted to lung isolation surgical technique. Dr. Campos previously held clinical appointments at UCLA School of Medicine Department of Anesthesiology. Dr. Campos received his medical training at the Autonomous University, Guadalajara, Mexico and performed his residency at the State General Hospital, Hermosillo, Sonora, Mexico. Dr. Campos holds multiple professional society appointments, including American Society of Anesthesiologists, International Anesthesia Research Society, and the Society of Cardiovascular Anesthesiologists. Dr, Campos is a member of the editorial board of the Journal of Cardiothoracic and Vascular Anesthesia.

William Edelman, co-Chairman of the Board for ETView commented, "We are thrilled to have Dr. Campos join our Scientific Advisory Board. Dr. Campos is an internationally respected clinician focused in the lung isolation surgical market. Dr. Campos will provide valuable counsel to ETView as we continue the commercial expansion world-wide for our TVT™ product line." Mr. Edelman continued, "We intend to recruit other clinicians of Dr. Campos' caliber to join him in our Scientific Advisory Board over the next few months." ETView's TVT™ combines high-flow ventilation airway management with continuous video monitoring to overcome current limitations and associated adverse surgical events during lung isolation surgeries.

About ETView Medical:

ETView Medical Ltd. (TASE: ETVW) is a commercial-stage, publicly traded medical device company that has successfully combined airway management with continuous direct airway visualization for medical professionals. ETView's patented TVT™ technology saves physician procedure time and is expected to provide better patient outcomes in multiple thoracic surgical procedures as well as with chronic ventilator dependent patients. Currently selling in Europe, Israel, and the U.S., the worldwide distribution network for ETView's lead proprietary product, the TVT™ combines high-flow ventilation airway management with continuous video monitoring to overcome current limitations and associated adverse surgical events during lung isolation surgeries. TVT™ has shown to be useful in limiting potential surgical injuries resulting from percutaneous tracheostomies. Visit ETView for additional information at www.etview.com.